Weiquan Bu

911 total citations · 1 hit paper
13 papers, 745 citations indexed

About

Weiquan Bu is a scholar working on Molecular Biology, Clinical Biochemistry and Cancer Research. According to data from OpenAlex, Weiquan Bu has authored 13 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 4 papers in Cancer Research. Recurrent topics in Weiquan Bu's work include Advanced Glycation End Products research (4 papers), Natural product bioactivities and synthesis (2 papers) and Autophagy in Disease and Therapy (2 papers). Weiquan Bu is often cited by papers focused on Advanced Glycation End Products research (4 papers), Natural product bioactivities and synthesis (2 papers) and Autophagy in Disease and Therapy (2 papers). Weiquan Bu collaborates with scholars based in China, Macao and United States. Weiquan Bu's co-authors include Wenbo Ding, Jie Song, Xiao‐Bin Jia, Liang Feng, Xiaobin Tan, Wei Wang, Guoguang Liu, Qing Ning, Yi Luo and E Sun and has published in prestigious journals such as Journal of Ethnopharmacology, RSC Advances and International Journal of Biological Macromolecules.

In The Last Decade

Weiquan Bu

11 papers receiving 736 citations

Hit Papers

Scutellaria baicalensis Georgi polysaccharide ameliorates... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota
    2020 354 citations Li Cui, Wenbo Ding et al. International Journal of Biological Macromolecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiquan Bu China 9 443 111 107 91 83 13 745
Xiangliang Deng China 16 319 0.7× 74 0.7× 159 1.5× 88 1.0× 72 0.9× 24 720
Xiaojun Zhang China 18 452 1.0× 104 0.9× 109 1.0× 121 1.3× 68 0.8× 25 773
Youliang Xie China 16 425 1.0× 94 0.8× 83 0.8× 60 0.7× 43 0.5× 31 827
Supriya R. Hyam South Korea 10 440 1.0× 79 0.7× 83 0.8× 81 0.9× 61 0.7× 10 733
Deborah Fratantonio Italy 17 502 1.1× 64 0.6× 101 0.9× 59 0.6× 56 0.7× 24 986
Linna Liu China 18 327 0.7× 54 0.5× 85 0.8× 60 0.7× 55 0.7× 56 726
Jiazhen Wu China 19 436 1.0× 90 0.8× 101 0.9× 100 1.1× 100 1.2× 39 934
María C. Recio Spain 14 323 0.7× 69 0.6× 151 1.4× 78 0.9× 66 0.8× 24 770
Yongqing Cai China 15 291 0.7× 58 0.5× 88 0.8× 46 0.5× 49 0.6× 29 612
Yeong‐Geun Lee South Korea 18 427 1.0× 46 0.4× 190 1.8× 114 1.3× 86 1.0× 79 855

Countries citing papers authored by Weiquan Bu

Since Specialization
Citations

This map shows the geographic impact of Weiquan Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiquan Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiquan Bu more than expected).

Fields of papers citing papers by Weiquan Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiquan Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiquan Bu. The network helps show where Weiquan Bu may publish in the future.

Co-authorship network of co-authors of Weiquan Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiquan Bu. A scholar is included among the top collaborators of Weiquan Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiquan Bu. Weiquan Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Ding, Wenbo, Xiuwei Chen, Yaping Chen, et al.. (2022). Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway. Integrative Cancer Therapies. 21. 1553394024–1553394024. 9 indexed citations
4.
Zhu, Maomao, Juan Chen, Bing Yang, et al.. (2021). Characterization of a novel polysaccharide from Moutan Cortex and its ameliorative effect on AGEs-induced diabetic nephropathy. International Journal of Biological Macromolecules. 176. 589–600. 38 indexed citations
5.
Cui, Li, Wenbo Ding, Yi Luo, et al.. (2020). Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. International Journal of Biological Macromolecules. 166. 1035–1045. 354 indexed citations breakdown →
6.
Li, Ru, Yaping Chen, Weiquan Bu, et al.. (2020). The structural composition of components contributes to the superiority of the geoherbAlisma orientalefor “diuresis and diffusing dampness”. RSC Advances. 10(65). 39385–39395. 6 indexed citations
7.
Chen, Juan, Di Zhao, Maomao Zhu, et al.. (2017). Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. Biomedicine & Pharmacotherapy. 89. 1362–1369. 46 indexed citations
8.
Liu, Ying, Ziyu Jiang, Huihui Qiu, et al.. (2017). β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway. Biomedicine & Pharmacotherapy. 93. 490–497. 56 indexed citations
9.
Cui, Li, Weiquan Bu, Jie Song, et al.. (2017). Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway. Archives of Pharmacal Research. 41(3). 299–313. 106 indexed citations
10.
11.
Yang, Nan, Zibo Dong, Gang Tian, et al.. (2016). Protective effects of organic acid component from Taraxacum mongolicum Hand.-Mazz. against LPS-induced inflammation: Regulating the TLR4/IKK/NF-κB signal pathway. Journal of Ethnopharmacology. 194. 395–402. 36 indexed citations
12.
Wang, Chunfei, Jiarui Yuan, Dong Qin, et al.. (2016). Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats. Journal of Ethnopharmacology. 185. 162–170. 55 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangliang Deng Breakdown of academic impact, for papers by Xiaojun Zhang Breakdown of academic impact, for papers by Youliang Xie Breakdown of academic impact, for papers by Supriya R. Hyam Breakdown of academic impact, for papers by Deborah Fratantonio Breakdown of academic impact, for papers by Linna Liu Breakdown of academic impact, for papers by Jiazhen Wu Breakdown of academic impact, for papers by María C. Recio Breakdown of academic impact, for papers by Yongqing Cai Breakdown of academic impact, for papers by Yeong‐Geun Lee
Rankless by CCL
2026